Loading company…
Moonwalk Biosciences develops epigenetic medicines for complex diseases.
Moonwalk Biosciences uses epigenetic profiling and engineering to identify disease targets and develop therapies. It also offers epigenetic editing and clinical product development services. Founded in 2022, the company is based in South San Francisco, US. In September 2026, it raised USD 70 million in Series B funding co-led by Alpha Wave Global and YK Bioventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in